Evidence map›Paper›PMID 40678802›Full record

ArticleBiochemistry and biophysics reports2025

Promotive role of MBNL3 and PXN genes expressions with lncRNA PXN-AS1-L on gastric cancer.

Mai A H Abouelenin, Amany A Saleh, Naglaa S Elabd, Osama Elbahr, Reham Ahmed Abdelaziz, Mohammed G Elhelbawy, Zeinab A Kasemy, Ahmed Abdelkhalek Hussein, Mona A Abbas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mai A H AboueleninMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.
Amany A SalehMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.
Naglaa S ElabdTropical Medicine Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.
Osama ElbahrHepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Shebin El Kom, 32511, Egypt.
Reham Ahmed AbdelazizClinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.
Mohammed G ElhelbawyClinical Pathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.
Zeinab A KasemyPublic Health and Community Medicine Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.
Ahmed Abdelkhalek HusseinOncology Department, Radiation Oncology Section, King Faisal Specialist Hospital and Research Center (KFSHRC), KSA, P.O. Box 40047, Jeddah, 21499, Saudi Arabia.
Mona A AbbasMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, 32511, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer ranks fourth in both incidence and mortality worldwide. Several genes influence its genesis and progress. Materials and methods: The expression of MBNL3, PXN genes, and lncRNA PXN-AS1-L was evaluated in gastric tissue samples from 75 gastric cancer patients and 75 controls by RT-PCR. Results: MBNL3, PXN, and lncRNA PXN-AS1-L expressions were considerably raised among cancerous gastric tissue than in nearby normal tissue and normal tissue from controls (p < 0.001). LncRNA PXN-AS1-L and MBNL3 had the highest sensitivity (92.00 % and 90.67 %, respectively), with PXN sensitivity of 81.33 % for differentiation of the cancer tissue from adjacent normal tissue, while PXN and lncRNA PXN-AS1-L had the highest sensitivity (98.67 % and 92.00 %, respectively), with 89.33 % for MBNL3 as discriminators between gastric cancer tissue and normal tissue from controls. Between metastatic and non-metastatic patients, MBNL3 and PXN were the highest differentiating markers (sensitivity = 87.50 % and 83.33 %, respectively). MBNL3, PXN, and lncRNA PXN-AS1-L were reliable predictors of gastric cancer (p = 0.004, p = 0.009, and p = 0.001, respectively), but only MBNL3 and lncRNA PXN-AS1-L were significant predictors for mortality (p = 0.026 and p = 0.043, respectively). The elevated expressions were linked to lower overall and progression-free survival rates. Conclusion: MBNL3, PXN, and lncRNA PXN-AS1-L expression levels can diagnose and predict gastric cancer and discriminate between metastatic and non-metastatic patients. The expression level of MBNL3 and lncRNA PXN-AS1-L can predict gastric cancer mortality. Higher expression of MBNL3 and PXN was linked to aggressive gastric cancer and low overall and progression-free survival rates.

Indexed as

Alternative splicingExpressionGastric cancerlncRNA

Identifiers

PMID40678802
PMCPMC12268067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.